One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth
New ‘Advisory Committee’ Under NITI Aayog To Regulate Prices Of Medicines; NPPA Won’t Be Undermined, Says Centre
Hindustan Unilever Found Guilty Of Rs 383 Crore Profiteering For Not Passing On GST Rate-Cut Benefits To Customers
Indian Stents ‘Equally Good’ As The Best In The Market, Study Rubbishes Claims Of Superiority By Foreign Manufacturers
Why Modi Government’s Bid To Control Price Of Coronary Stents Hasn’t Yielded Desired Result
